Drug Shortage Report for METVIX
Report ID | 193468 |
Drug Identification Number | 02323273 |
Brand name | METVIX |
Common or Proper name | methyl aminolevulinate |
Company Name | GALDERMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | METHYL AMINOLEVULINATE |
Strength(s) | 168MG |
Dosage form(s) | CREAM |
Route of administration | TOPICAL TOPICAL |
Packaging size | 2 g |
ATC code | L01XD |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-05-31 |
Actual start date | 2023-05-31 |
Estimated end date | 2023-07-15 |
Actual end date | 2023-07-07 |
Shortage status | Resolved |
Updated date | 2023-07-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 55 COMMERCE VALLEY DRIVE WEST THORNHILL, ONTARIO CANADA L3T 7V9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-07-10 | French | Compare |
v4 | 2023-07-10 | English | Compare |
v3 | 2023-06-01 | English | Compare |
v2 | 2023-05-31 | French | Compare |
v1 | 2023-05-31 | English | Compare |
Showing 1 to 5 of 5